How a Tick Bite Sensitizes the Immune System to Alpha-Gal

A tick bite is not an infection. It is an injection — a slow, steady drip of spit loaded with molecules that reshape how the body's defense system reacts. Some of those molecules carry a tiny sugar that the human body treats as a stranger. That sugar is "galactose-α-1, 3-galactose (α-gal)" (FrontImmunol 2019), and the "Development of specific IgE antibodies" (FrontImmunol 2019) to it "following tick bites has been shown to be the source of red meat allergy" (FrontImmunol 2019). IgE is the kind of antibody the body makes when it thinks something is an allergen. For a full overview of alpha-gal syndrome as a clinical condition — its symptoms, severity spectrum, and diagnostic picture — see Alpha-Gal Syndrome Explained.

What makes this allergy unlike any other is how it starts. "Sensitization" is the moment the immune system first learns to treat something as a threat. As one review summarized, there are "several features that make the α-Gal syndrome such a unique allergic disease" (FrontAllergy 2021): "symptoms causing IgE antibodies are directed against a carbohydrate moiety" (FrontAllergy 2021), there is an "unusual delay between the consumption of the food and the onset of the symptoms" (FrontAllergy 2021), and "primary sensitization to α-Gal occurs via tick bites" (FrontAllergy 2021). In plain terms: the allergy is to a sugar rather than a protein, reactions show up hours after eating rather than right away, and the trigger that starts it all is a tick bite. The specific foods, medications, and products that trigger reactions once sensitization has occurred are covered in Alpha-Gal Reaction Triggers.

This article traces the biological chain from bite to allergy: which ticks carry alpha-gal (the sugar), how they deliver it during feeding, and what that delivery does to the human immune system.

Which Ticks Cause Alpha-Gal Syndrome?

AGS stands for alpha-gal syndrome — the meat allergy triggered by a tick bite. In North America, "the lone star tick, Amblyomma americanum, has been identified as the main culprit for AGS" (SciRep 2023). The lone star tick is a common tick across the southern and eastern U.S., named for the single white dot on the female's back. The CDC — the U.S. Centers for Disease Control and Prevention — tracked where suspected cases showed up and found the same pattern: "Suspected AGS cases were predominantly located in areas where the lone star tick (Amblyomma americanum) is known to be established or reported" (CDC 2023). A broader species profile of the lone star tick — its expanding range, other diseases it transmits, and its ecology — is covered in The Lone Star Tick (Amblyomma americanum).

But the map is not that simple. The CDC also noted that "alpha-gal has been identified in the saliva of other tick species" (CDC 2023), and that "bites from other tick species are associated with AGS in other parts of the world" (CDC 2023). A 2025 CDC investigation documented the condition in Maine after a person was bitten by a black-legged tick (also called the deer tick, the tick that spreads Lyme disease). The report noted that "The α-gal molecule is found in saliva or salivary glands of Haemaphysalis longicornis and Ixodes scapularis ticks" (CDC-EID 2025) — that is, the Asian longhorned tick and the black-legged (deer) tick. Salivary glands are the organs that make spit.

The global picture extends further. Research has identified tick species implicated in AGS on multiple continents, including Australia, Europe, Japan, and Brazil:

"Outside of the US, other tick species have been identified that may also be involved in the development of AGS including Ixodes holocyclus in Australia, Ixodes ricinus, Rhipicephalus bursa, and Hyalomma marginatum in Europe, Haemaphysalis longicornis in Japan, and Amblyomma sculptum in Brazil. " — FrontImmunol, 2019. Discovery of Alpha-Gal-Co...

A 2025 immunology review put a number on it: "Alpha-gal sIgE in AGS is associated with bites from thirteen tick species around the world" (PMC 2025). Here "sIgE" means "specific IgE" — the allergy-style antibody aimed specifically at alpha-gal.

Not all ticks carry equal risk

Lab studies show sharp differences among North American ticks. A 2019 study used special proteins that stick only to alpha-gal to check four tick species side by side. It found that "Anti-α-gal antibodies identified α-gal in the salivary glands of both Am. americanum and Ix. scapularis, while Am. maculatum and De. variabilis appeared to lack the carbohydrate" (FrontImmunol 2019) — meaning the lone star tick and the black-legged (deer) tick carried the sugar, while the Gulf Coast tick and the American dog tick did not. A separate sugar-analysis test confirmed it: "Am. americanum and Ix. scapularis have α-gal in their saliva and salivary glands, but Am. maculatum contains no detectable quantity" (FrontImmunol 2019). Different ticks, different risk.

Those differences matter for the immune system, not just on paper. Researchers mixed tick saliva with basophils — a type of white blood cell that helps drive allergic reactions — taken from people with alpha-gal allergy. Saliva from ticks that carry the sugar "stimulated activation of basophils primed with plasma from α-gal allergic subjects" (FrontImmunol 2019), while saliva from the Gulf Coast tick (Amblyomma maculatum) "caused small but non-significant increases in CD63+ basophils" (FrontImmunol 2019) — meaning the effect was too small to count as a real signal. Ticks that carry alpha-gal set off allergy cells; ticks that do not, basically do not.

Why does the black-legged tick rarely cause AGS in the U.S.?

This is one of the open puzzles. A 2025 review for infectious-disease doctors noted: "Like LSTs, Ixodes scapularis ticks also possess AG in their saliva. Additionally, I scapularis salivary samples stimulated basophils primed with plasma from AGS subjects in vitro. However, I scapularis tick bites have historically not been associated with AGS development" (PMC 2025). (Here "LSTs" means lone star ticks, "AG" means alpha-gal, and "in vitro" means in a lab dish rather than inside a person.) The authors added that "Variations in tick saliva composition, feeding behavior, and other ecologic factors for I scapularis ticks have been suggested as explanations, but remain unproven" (PMC 2025). In other words, the saliva looks capable of starting the allergy in a lab, but something about how deer ticks actually bite people usually does not.

That may be changing. In addition to the Maine case, "2 recent case reports in the US linked the development of AGS to Ixodes tick bites (1 to an I scapularis bite and 1 to an Ixodes pacificus bite), suggesting that this potential connection should be further investigated" (PMC 2025). Ixodes pacificus is the western black-legged tick, a close cousin of the eastern deer tick that lives along the U.S. West Coast.

Beyond ticks: other possible sensitizers

Tick bites are the main trigger, but they may not be the only one. A report from Uganda described "AGS arising in patients in Uganda after tsetse fly bites, with elevated alpha-gal sIgE levels and hypersensitivity responses hours after mammalian meat consumption" (PMC 2025) — tsetse flies are large biting flies found in parts of Africa. Beyond biting insects, "The most compelling non–tick bite factor that may contribute to AGS development is exposure to the helminth Ascaris lumbricoides" (PMC 2025) — a helminth is a parasitic worm, and Ascaris lumbricoides is a roundworm that can live in the human intestine. One study found that "high Ascaris IgE levels correlated more strongly with AGS than did tick bites in Africa" (PMC 2025).

There are also reports that chiggers (tiny biting mite larvae) and some stinging insects may play a role. One clinical review noted that "AG IgE has also been linked to cat ownership and to cat flea bites. Trombiculidae larvae (chigger) bites have also been linked to AGS" (PMC 2025). On stings from bees, wasps, and their relatives, "It is not clear, however, whether stinging insect envenomation itself can drive the initial alpha-gal IgE response apart from tick bites" (T&F 2020) — meaning researchers have not figured out whether the stinger alone, without a prior tick bite, is enough to start the allergy.

How Does a Tick Bite Trigger the Alpha-Gal Meat Allergy?

Starting the allergy takes two things at once: alpha-gal has to get under the skin, and the immune cells nearby have to be nudged into "allergy mode" — the setting that makes IgE antibodies instead of ordinary ones. A feeding tick does both at the same time.

The delivery: alpha-gal in tick saliva

When ticks feed, they "secrete and introduce a plethora of salivary secretions that modulate the host immune responses" (FrontCellInfectMicrobiol 2021) — that is, they inject many different spit molecules that tamper with the host's immune system. One of those molecules is alpha-gal itself. Researchers have pinpointed exactly where it sits inside the tick: "Immunolocalization of α-gal moieties to the salivary secretory vesicles of the salivary acini also confirmed the secretory nature of α-gal-containing antigens in ticks" (FrontImmunol 2019). Simply put, alpha-gal is packed into the little sacs inside the salivary gland that squirt spit out — so it rides along with every drop the tick injects while feeding.

A key finding was that the alpha-gal is not just leftover blood from the tick's last meal. Human blood does not contain alpha-gal, so if ticks fed only on humans had none either, that would point to a dietary origin. Researchers tested this. When they fed lone star ticks on human blood, "Am. americanum ticks that were artificially fed with human blood still contained α-gal at the same molecular weight as ticks fed sheep blood" (FrontImmunol 2019). Sheep blood, unlike human blood, is full of alpha-gal. The researchers concluded that "These results indicate that ticks possibly recycle host glycans or synthesize α-gal using alternative methods" (FrontImmunol 2019) — meaning the ticks either recycle sugars left over from earlier meals, or build the sugar themselves.

A 2021 review pulled the evidence together: "three genes involved in the synthesis of α-Gal have been identified in I. scapularis genome and the presence of α-Gal has also been confirmed in Amblyomma americanum ticks fed on human blood, which lacks α-Gal. All these findings support the view that α-Gal moieties present in tick tissues and saliva do not originate from a prior blood meal but are produced by the ticks themselves." (FrontAllergy 2021) In short: the black-legged tick has the genetic instructions to make alpha-gal, and the lone star tick still has alpha-gal even after drinking blood that contains none — so the tick is making the sugar itself.

There is still a puzzle, though. Most mammals build alpha-gal using a specific enzyme — a protein that acts like a tiny molecular tool — called alpha-1,3-galactosyltransferase. That tool has not been spotted anywhere in the tick's genetic code. As one research group put it, "Intriguingly, the key enzyme, α1,3-GT, which synthesizes α-gal, remains unidentified in tick genomes" (FrontCellInfectMicrobiol 2021). So how do ticks end up with alpha-gal at all? Three possible explanations are being investigated:

"We have yet to identify α-1,3-galactosyltransferase in Am. americanum or Ix. scapularis, but our combined results provide evidence that terminal α-1,3-galactose residues exist in the saliva and salivary glands after the initiation of feeding, both from human and animal hosts, which leads us to believe that there are three possible scenarios that could lead to synthesis:

  • The glycans are captured by lectins and modified with glycoside hydrolases and glycosyltransferases,
  • galactosyltransferase enzymes from bacterial species contained in the normal microbiota or vectored by of Am. americanum or Ix. scapularis are responsible for the α-gal glycan,
  • some ticks contain an uncharacterized enzyme with a similar or equivalent function to α-1,3-galactosyltransferase, which is yet to be investigated.

" — FrontImmunol, 2019. Discovery of Alpha-Gal-Co...

Feeding duration and alpha-gal dosing

The amount of alpha-gal a tick puts into a bite is not constant — it changes over the days the tick stays attached. The lone star tick's saliva and salivary glands "express α-gal-containing antigens in a time-dependent manner throughout prolonged blood feeding" (FrontImmunol 2019). Put plainly: the longer the tick feeds, the more alpha-gal the saliva carries. A 2025 review said it straight: "The longer Aa ticks feed, the more alpha-gal is detectable in tick saliva" (PMC 2025) (Aa is short for Amblyomma americanum, the lone star tick).

A 2023 study in Scientific Reports found this rise shows up quickly: "Our results also show that the aGal levels in tick SG fed on human blood increase significantly over the course of feeding, with an increase seen as early as day 3 of tick feeding in the OKL tick strain" (SciRep 2023). Here "SG" is salivary gland, "aGal" is alpha-gal, and "OKL" is just the name of one group of lab ticks. Nobody has measured the exact amount of alpha-gal it takes to push a human immune system into allergy mode, so this research points a direction rather than fixing a rule. With that caveat, the researchers proposed that "our findings suggest that early tick removal would be a preventative measure to reduce the risk of AGS" (SciRep 2023) — the sooner you get the tick off, the less alpha-gal ends up under the skin.

Ticks feeding on human blood produce more alpha-gal

One of the most striking findings came from comparing alpha-gal levels across different kinds of blood the tick fed on. Paradoxically, the ticks carried more alpha-gal when they fed on humans — the one blood source that contains no alpha-gal at all. The same 2023 study reported that "We found significantly higher aGal levels in the female ticks fed on human blood than those fed on the blood of other mammals with large variations among different tick populations and individuals" (SciRep 2023). In the same study, a handful of individual ticks fed on human blood produced shockingly high levels — "A few ticks showed noticeably high levels of aGal, up to 3325 pmol/tick" (SciRep 2023). That unit (pmol/tick) just measures how many alpha-gal molecules are inside a single tick; the headline is that the amounts varied wildly from one tick to the next.

This wide range from one tick to the next may itself matter. The researchers proposed that "the high levels of aGal and the large variation in the levels of tick salivary aGal, the sensitizer for AGS, are factors contributing to the variation in the manifestation of AGS" (SciRep 2023) — meaning some bites deliver a hefty dose of the allergy-triggering sugar and others almost none, which could help explain why AGS shows up in some people and not others.

The U.S. Department of Health and Human Services (HHS) summed up the findings for policymakers in a review of tick-borne disease research: "A study of tick saliva found great variability in the amount of alpha-gal in lone star tick saliva, with generally higher amounts found in ticks fed primarily on human blood. These findings suggest that hostspecific genetic components affect the production of alpha-gal in tick saliva and may contribute to variability in the development of AGS" (HHS 2024). "Host-specific genetic components" just means something in the host's DNA — human versus cow, for example — seems to change how much alpha-gal the tick ends up carrying.

The immune shift: from alpha-gal delivery to IgE production

Alpha-gal getting into the skin through tick saliva is only half the story. Even before any tick bite, the human immune system already makes antibodies against alpha-gal — "Humans make high titers of IgG, IgM, and IgA antibodies against alpha-gal, thought to be driven by exposure to alpha-gal in the diet and in components of commensal microbes" (PMC 2025). IgG, IgM, and IgA are everyday antibody classes the body uses for normal housekeeping; "commensal microbes" are the harmless bacteria that live in the gut. What the tick bite does differently is switch the immune system over to making IgE — the allergy-style antibody. IgE attaches to mast cells and basophils, the cells that release histamine and cause the hives, swelling, and stomach trouble people feel during an allergic reaction.

A 2025 review for infectious-disease doctors put this contrast in plain terms: "Human exposure to AG in tick saliva specifically leads to the production of IgE antibodies to AG, while exposure to AG in the gastrointestinal tract results only in IgM, IgG, and/or IgA antibody production" (PMC 2025). Same sugar, different route — alpha-gal through the gut produces ordinary antibodies, while alpha-gal injected through tick spit produces allergy antibodies.

How does a tick bite cause this switch? Tick saliva is a complicated cocktail of molecules that tampers with how the immune system behaves. A 2021 review in Frontiers in Allergy described the chain of events:

"The saliva of ticks is a complex mixture of substances, several of them also with immunomodulatory properties. With the injury caused by the tick mouthparts that disrupt the epidermis and enter the dermis of the host skin, the mechanisms of wound healing begin in the host: coagulation, vasoconstriction, and platelet aggregation are followed by responses of the innate and adaptive immune system. For an effective blood feeding, the tick must be able to counteract the defense mechanisms of the host. Indeed, bioactive molecules present in the tick saliva can suppress the host's hemostatic as well as immune responses that impede efficient feeding and that might damage the tick. Tick saliva has been shown to decrease the production of the proinflammatory mediators IL-12, IL-1β or TNF-α, while promoting an increased expression of anti-inflammatory cytokines like TGF-β or IL-10. These effects might be mediated by molecules such as Prostaglandin E2 (PGE2), which is very abundant in tick saliva. PGE2 induces vasodilation and impairs wound healing while reducing inflammation. " — FrontAllergy, 2021. The α-Gal Syndrome and Po...

One ingredient in tick saliva that seems to matter a lot is called prostaglandin E2 (PGE2) — a small signaling molecule that tells nearby immune cells how to behave. Tick saliva has a lot of it. As one research group noted, "The tick saliva has been shown to contain proteins carrying α-Gal, but also bioactive molecules, such as prostaglandin E2, which is capable of stimulating an increased expression of anti-inflammatory cytokines while promoting a decrease in the production of proinflammatory mediators" (FrontAllergy 2021). In plain terms: PGE2 turns down the body's normal inflammation response at the bite site. Cytokines are the short messages immune cells send to each other, and PGE2 shifts the balance of those messages toward "calm down" rather than "fight." Together with alpha-gal-carrying proteins, these ingredients "might promote Th2-related immunity and trigger a class switch to IgE antibodies directed against the oligosaccharide α-Gal" (FrontAllergy 2021) — meaning the immune system gets nudged into the same mode it uses for allergies, and starts making IgE antibodies against alpha-gal.

Experiments in mice have tested the full chain. Researchers used special mice that are bred to lack alpha-gal, so their immune systems react to it much the way a human immune system does. They exposed these mice to ground-up tick salivary glands, and watched the mice start producing IgE antibodies and then react to mammal meat:

"To investigate how tick bites can initiate the anti-α-Gal IgE response, Choudhary et al. made use of an α-Gal knockout mouse model. They saw that sensitization with tick salivary gland extract caused the generation of IgE antibodies to α-Gal and the development of allergic reactions to mammalian meat. These experiments illustrate the important role of the tick saliva for the development of α-Gal allergy. " — FrontAllergy, 2021. The α-Gal Syndrome and Po...

A later study showed that "infesting AGKO mice multiple times with nymphal lone star ticks amplified alpha-gal sIgG1 and sIgE and predisposed mice to anaphylaxis when fed mammalian meat" (PMC 2025). "AGKO" means the alpha-gal-deficient mice described above; "nymphal" ticks are the young, poppy-seed-sized stage between larva and adult; and anaphylaxis is a severe, whole-body allergic reaction. Each extra round of bites pushed the allergy response higher.

The role of glycolipids and unconventional immune pathways

The way the body learns to fight alpha-gal may not follow the usual textbook steps for allergies. A 2021 review explained the puzzle: "Immune responses to carbohydrates are thought to occur without T cell help. However, the production of IgE antibodies involves class-switching that requires the input from T cells" (FrontAllergy 2021). T cells are a kind of white blood cell that tells other immune cells which antibodies to make. Normally, reactions to sugars (carbohydrates) happen without T cells, but IgE antibodies cannot be made without them — so something has to recruit T cells here. Researchers have had to look past the usual helper cells for what that something is.

One leading idea involves a special white blood cell called the invariant natural killer T cell — iNKT cell for short. Unlike most T cells, which recognize protein fragments, iNKT cells can recognize sugars linked to fats (glycolipids). A 2021 review noted that alpha-gal glycolipids in tick saliva "might be recognized by iNKT cells, which can then produce IL-4" (FrontAllergy 2021). IL-4 is a signaling molecule (a cytokine) that pushes B cells to make IgE antibodies. Supporting the theory, researchers found "a trend toward increased frequencies of activated, CD69 + circulating iNKT cells in volunteers with AGS compared to controls" (PMC 2025) — meaning AGS patients had more of these switched-on iNKT cells in their blood than healthy volunteers did.

Tick saliva carries alpha-gal in two flavors — attached to proteins and attached to fats — and both flavors do the job: "Aa tick saliva contains both alpha-gal-glycosylated proteins and lipids. These protein and lipid saliva fractions activate human basophils passively sensitized with sera containing alpha-gal sIgE from participants with AGS" (PMC 2025). In a lab dish, both forms were able to trigger the allergy-driving basophil cells from people who already have AGS.

Repeated bites amplify the response

The allergy response appears to stack up over time — each additional bite adds to it. As early studies noted, "Surprisingly, continued exposure to tick bites seems to augment the already existing sIgE antibody response" (FrontImmunol 2019). Following patients over years tells the same story: "Longitudinal data of patients with AGS suggest that alpha-gal IgE declines over time; additional tick bites, however, appear to lead to rises in alpha-gal IgE" (T&F 2020). ("Longitudinal" just means patients were tracked over a long stretch of time.) Without new bites, alpha-gal IgE fades; with new bites, it climbs again.

A study comparing AGS patients with healthy volunteers gave concrete numbers. Researchers found that "patients with AGS were significantly more likely to report 4 or more tick bites and noted localized reactions to tick bites significantly more often than controls without AGS" (PMC 2025). "Localized reactions" here means the itchy, red, swollen spot that lingers around a bite. A 2025 summary added that "frequent tick exposure appears to pose a greater risk for elevated alpha-gal IgE than a single prolonged exposure during tick attachment" (PMC 2025) — in other words, many bites over time seem to push IgE up more than one long bite does.

The microbiome connection

Ticks carry their own mix of bacteria inside them, and some of those bacteria may add to the alpha-gal getting delivered in the bite. A 2021 study noted that "Few studies have reported that tick-borne bacteria such as Anaplasma phagocytophilum and Borrelia burgdorferi sensu lato express α-gal and increase α-gal signature in ticks, hence, the role of tick microbiome as one possible source of α-gal cannot be negated" (FrontCellInfectMicrobiol 2021). Anaplasma phagocytophilum is the bacterium that causes anaplasmosis, and Borrelia burgdorferi is the bacterium that causes Lyme disease; both make their own alpha-gal, so a tick carrying them holds more of the sugar overall. A 2023 study looked at a different kind of bacteria — endosymbionts, which are bacteria that live permanently inside the tick's cells: "A recent study proposed that an invasion of Francisella -like endosymbiont (FLE) replacing Coxiella-like endosymbiont (CLE) in A. americanum is associated with AGS" (SciRep 2023) — meaning one kind of built-in bacteria in lone star ticks may be replacing another, and that swap might link to AGS. The researchers noted a wrinkle, though: the genomes of these endosymbionts "do not contain bacterial alpha-1,3-galactosyltransferase gene" (SciRep 2023) — meaning neither one carries the usual instructions for building alpha-gal.

Blood type and individual susceptibility

Not everyone bitten by an alpha-gal-carrying tick ends up with the allergy. One clue researchers have been chasing is blood type. A 2020 review laid out the idea:

"The working hypothesis to explain the effect of blood type on alpha-gal sensitization and allergy proposes that subjects with blood type B make low quantities of alpha-gal IgE with possibly low binding affinity for alpha-gal. Alpha-gal is closer in structure to blood type B than to A and O; individuals with blood type B may be less likely to create an antibody against a foreign carbohydrate (alpha-gal) very similar in structure to a self-carbohydrate (group B antigen).

" — PMC, 2020. "Doc, Will I Ever Eat St...

A 2025 review for doctors confirmed that "The B-group antigen affords protection against developing AGS, although protection is not 100%" (PMC 2025) — meaning having type B or AB blood makes AGS less likely, but is not a full shield. The same review also noted that "a history of atopy may increase the risk of AGS development" (PMC 2025). "Atopy" is the tendency to develop allergic conditions like eczema, asthma, or hay fever; a family or personal history of these seems to raise the odds of AGS.

The other big risk factors mostly boil down to how likely a person is to get bitten in the first place: "Risk factors for developing sIgE to α-Gal are related to the probability of individual tick bite-exposure in certain environmental conditions, including practice of outdoor activities (eg, hunting or hiking), living in rural areas, pet-ownership, and certain jobs such as forest service employees" (PMC 2022) — basically, more time outdoors in tick habitat means more chances for a bite that could start AGS.

The sensitization-to-symptom gap

Even people who make IgE antibodies against alpha-gal often never have an allergic reaction to meat. As one 2023 study noted, "only a subset of the human population exposed to lone star tick bites develops AGS. This suggests the presence of unidentified variables associated with the sensitization event" (SciRep 2023) — there are hidden ingredients in who ends up with the allergy that researchers have not pinned down. A 2022 review made the same point: "not all individuals bitten by ticks or those that carry elevated specific IgE (sIgE) against α-Gal develop AGS, in fact, the majority only produce sIgE against it" (PMC 2022). Carrying the allergy antibody and actually having the allergy are not the same thing.

What tips a person from simply carrying the antibody into actually reacting to meat is one of the biggest open questions in AGS research. The pieces researchers have found so far — blood type, how many bites a person has had, and the wild variation in how much alpha-gal different ticks carry — each shift the odds a little, but together they still do not fully explain why one person develops AGS and another, bitten the same number of times, does not.

Sources

    Not medical advice. See a healthcare provider for medical decisions. Medical Disclaimer